To: hoffy who wrote (26937 ) 12/12/1998 10:35:00 AM From: Gregg Sterner Respond to of 119973
ASTM starts its clinical trials within 3 weeks in Europe. It also holds 16 patents in stem cell technology. Additionally it has already licensed many of those patents to other companies. Therefore, they are now starting to generate revenue. All of this has been reported in the links previously given here over the last few days. They are producing and generating revenue now and they start live patient trials in 3 weeks, not next year. Also, their cord blood processes are in clinical use here in the US on a case by case basis as shown in the CNN link posted here earlier today. Yes, CEGE will be a bid player also in its turn just as ASTM, CTII, and many others will be players over this next year. The iNet stocks had short wind big revenues and even bigger debt. The BioSciences, which are more numerous than iNets and lifesaving to boot, are just now coming into the forefront of the industry. We all will have prosperous trading here for a long time. No matter what our preferences. The key here will be that we are all willing to share our information with each other so that we can all make a living at it. As most of you will agree, we do our DD and really learn about the companies that we trade, unlike those so called DayTraders in those New York bullpens that are being shown on TV as the typical DayTrader. Blaaaaaaaaaaaa and Spit. We dig out news articles for others to read and we research those boring SEC filings for confirmation to hype. We are the real DayTraders. We are the Grass Roots movement of America when it comes to Trading so lets sit back and enjoy it rather than piss in it. Cheers, Gregg